.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cipla
Baxter
Fish and Richardson
Johnson and Johnson
Argus Health
Queensland Health
Colorcon
Moodys
Dow

Generated: December 14, 2017

DrugPatentWatch Database Preview

Felbamate - Generic Drug Details

« Back to Dashboard

What are the generic sources for felbamate and what is the scope of felbamate patent protection?

Felbamate
is the generic ingredient in two branded drugs marketed by Amneal Pharms, Taro Pharm, Mylan Speciality Lp, Alvogen Malta, Impax Labs Inc, and Zydus Pharms Usa Inc, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for felbamate. Twelve suppliers are listed for this compound.

Pharmacology for felbamate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa IncFELBAMATEfelbamateTABLET;ORAL208970-001May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncFELBAMATEfelbamateTABLET;ORAL208970-002May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Speciality LpFELBATOLfelbamateSUSPENSION;ORAL020189-003Jul 29, 1993ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Alvogen MaltaFELBAMATEfelbamateTABLET;ORAL204595-001Jan 11, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Impax Labs IncFELBAMATEfelbamateTABLET;ORAL202284-001Nov 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amneal PharmsFELBAMATEfelbamateTABLET;ORAL201680-002Sep 13, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Alvogen MaltaFELBAMATEfelbamateTABLET;ORAL204595-002Jan 11, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amneal PharmsFELBAMATEfelbamateTABLET;ORAL201680-001Sep 13, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Speciality LpFELBATOLfelbamateTABLET;ORAL020189-001Jul 29, 1993ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Impax Labs IncFELBAMATEfelbamateTABLET;ORAL202284-002Nov 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: felbamate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality LpFELBATOLfelbamateSUSPENSION;ORAL020189-003Jul 29, 1993► Subscribe► Subscribe
Mylan Speciality LpFELBATOLfelbamateTABLET;ORAL020189-002Jul 29, 1993► Subscribe► Subscribe
Mylan Speciality LpFELBATOLfelbamateTABLET;ORAL020189-001Jul 29, 1993► Subscribe► Subscribe
Mylan Speciality LpFELBATOLfelbamateTABLET;ORAL020189-002Jul 29, 1993► Subscribe► Subscribe
Mylan Speciality LpFELBATOLfelbamateTABLET;ORAL020189-001Jul 29, 1993► Subscribe► Subscribe
Mylan Speciality LpFELBATOLfelbamateSUSPENSION;ORAL020189-003Jul 29, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Colorcon
Deloitte
Citi
Fuji
Fish and Richardson
McKesson
Covington
Cipla
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot